Table 1

Estimated number of genotype 1 HCV patients treated in France in 2010 and 2012 at unchanged screening rate

Treated in 2010*To be treated in 2012†
Scenario 1
Naive3,2005,500
 F0-F22,5003,600
 F3-F47001,900
Experienced1,9009,500
 F0-F21,3005,100
 F3-F46004,400
Total5,10015 000

  • ↵* With PEG-IFN/RBV.

  • ↵† With PEG-IFN/RBV+PI with the exception of 10% of treatment-naive, F0-F2 patients who will be treated with PEG-IFN/RBV.